Home / Stocks / APLS

APLS insider trading

Apellis Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-08-29Francois Cedric
Chief Executive Officer
Sold225,000$28.23$6.4M
2025-07-16Francois Cedric
Chief Executive Officer
Sold137,465$20.19$2.8M
2024-09-17Dunlop A. Sinclair
Director
Sold29,476$36.09$1.1M

See APLS on the chart

Every insider buy and sell for APLS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.